• Sweet Nostalgia with Warren Buffett and Bill Gates
    Posted by on June 20th, 2018 at 11:40 am

  • Morning News: June 20, 2018
    Posted by on June 20th, 2018 at 7:05 am

    Saudi Struggles For Gulf Oil Producers’ Support Ahead of OPEC Meeting

    China Tells Farmers To Grow More Soybeans Amid Trade Fight With U.S.

    Cryptocurrencies Fall as Korean Exchange Says $32 Million of Coins Stolen

    U.S. Growth Is ‘Close to a Peak’, But Risks Are Mounting

    Microsoft Employees Protest Work With ICE, as Tech Industry Mobilizes Over Immigration

    GE Drops Out of the Dow After More Than a Century

    Ford and Volkswagen Discuss Developing Vehicles Together

    Amazon Urged Not to Sell Facial Recognition Technology to Police

    PayPal Agrees to Buy Payments Firm Hyperwallet for $400 Million

    AT&T in Talks to Acquire AppNexus for About $1.6 Billion

    Can My Pension Lower My Social Security Benefits?

    Commerce Secretary Shorted Stock as Negative Coverage Loomed

    Nick Maggiulli: The Evil Hours

    Jeff Carter: Where Is Alpha?

    Ben Carlson: Too Big To Be Simple?

    Be sure to follow me on Twitter.

  • GE Kicked Out Of The Dow
    Posted by on June 19th, 2018 at 10:47 pm

    Dow Jones announced this afternoon that General Electric (GE) is being removed from the Dow Jones Industrial Average for Walgreens Boots Alliance (WBA).

    This isn’t completely unexpected. Here’s me three years ago:

    GE simply doesn’t make up much of the Dow. The stock closed today at $12.99. That means it makes up about 100 points in the Dow, which is currently at 24,700. The average Dow stock makes up over 800 points in the index.

    GE has been a Dow member for over 110 years. On November 7, 1907, General Electric replaced Tennessee Coal, Iron and Railroad Company in the Dow. GE was an original Dow stock in 1896 but it was dropped in 1898, added back in 1899, then dropped again 1901 and added back in 1907.

    I find it interesting that many dystopian movies feature powerful corporations (Pan-Am in 2001 or Atari in Blade Runner). In reality, these organizations come and go faster than you think.

    The current Dow divisor is 0.14523396877348. That means every $1 in a Dow stock is about seven Dow points. The divisor will now be adjusted for WBA. Here’s the GE chart going back 56 years:

  • This Week’s Divergence
    Posted by on June 19th, 2018 at 10:50 am

    It’s still early, but this is an arresting chart:

    This shows us that High Beta stocks are falling hard while the Low Volatility sector is barely scratched. This is a big divergence. It generally signals that investors are less willing to shoulder risk.

    The gap opened on Friday but narrowed as the day wore on. Then it got bigger yesterday, and today it’s quite large.

  • Morning News: June 19, 2018
    Posted by on June 19th, 2018 at 7:16 am

    What Will OPEC Let Slip for Crude Oil?

    5 Reasons The Drop In Gold Prices Shouldn’t Worry Investors

    Wealthy Asians Are Getting Rich Faster Than Anyone Else

    What Can Beijing Do If China-U.S. Trade Row Worsens?

    Why Would the Fed Want to Raise the Unemployment Rate a Full Percentage Point?

    Why Doesn’t Mr. Market Recognize The Iron Mountain Of Dividends?

    Mercari Jumps 77% in Tokyo Debut After $1.2 Billion IPO

    Fujifilm Sues Xerox for More Than $1 Billion After Canceled Merger

    American Airlines Partner Expects More Flight Cancellations This Week

    With Two Suitors for Fox, the Murdochs Consider Next Steps

    U.S. Homes Are a Lot Cheaper Than They Look, Harvard Study Finds

    Financial World’s A-List Could Take Hollywood’s Cue on Inclusion

    Howard Lindzon: Momentum Monday – Emerging Flu?

    Roger Nusbaum: 60/20/10/10?

    Joshua Brown: Why You Work Is Becoming as Important as What You Do

    Be sure to follow me on Twitter.

  • Morningstar on Ingredion
    Posted by on June 18th, 2018 at 11:01 am

    Ingredion (INGR) is a difficult company to describe. Morningstar does a pretty good job. If you’re a fan of INGR, I recommend giving this a read. There are so many good parts but here are some highlights:

    Ingredion (INGR) manufactures starches and sweeteners by wet milling and processing corn and other starch-based raw materials. The company steeps these raw materials in a water-based solution before separating the starches from coproducts (animal feed and corn oil). The starches are then further processed into starch and sweetener ingredients used primarily by the food and beverage industries, as well as the paper, corrugating, brewing, and personal care industries.

    The company classifies its products as either core or specialty ingredients, with core ingredients generating roughly 70% of companywide sales (as reported) and just below 50% of profits (based on our estimates). Core ingredients are typically commodity-grade, providing no pricing power for Ingredion. Ingredion sells roughly half of its core sales on a cost-plus basis. Specialty ingredients are value-added, requiring additional processing and, in many cases, proprietary formulations. They typically command twice the gross margins and enjoy twice the sales growth of core ingredients. Although we expect demand for Ingredion’s core ingredients to grow roughly in line with GDP in the regions where they are sold, specialty ingredient volume should grow in the mid- to high single digits.

    (…)

    The most appropriate lens through which to analyze Ingredion’s competitive advantage is our moat framework for commodity processors. Moaty businesses that operate in this space tend to benefit from switching costs, intangible assets, or cost advantage. For Ingredion, we see evidence of switching costs and intangible assets, but not cost advantage. Slightly more than 70% of companywide sales involve the processing of raw materials (corn, tapioca, potatoes, rice) purchased at market prices into commodity-grade starch and sweetener ingredients over which Ingredion commands no pricing power. We view this core ingredients business as having no moat. With roughly half of its sales priced on a cost-plus basis, the core ingredients business should generally deliver returns on invested capital in line with the company’s weighted average cost of capital.

    We believe Ingredion’s specialty ingredients business operates with a narrow moat and earns excess ROICs. As a result, it has served as the key driver of the positive economic profit spread witnessed on a companywide basis each year over the past decade. The evidence for switching costs and intangible assets stems predominantly from Ingredion’s specialty ingredients business, which accounts for slightly less than 30% of Ingredion’s sales and just over half of its profits.

    (…)

    Given the scale of Ingredion’s commodity operations, the qualitative evidence for a companywide moat is arguable. However, the quantitative evidence is strong. Ingredion’s ROICs have consistently exceeded the company’s weighted average cost of capital in recent years. Based on our calculations, ROICs have averaged 11.5% over the trailing 10-year period, safely above our assumed 8.2% WACC. Due primarily to an improving product mix driving very modest margin expansion, our midcycle ROIC forecast sits slightly above 12%, and we feel confident that economic profits will persist at least 10 years into the future. Although corn prices, Ingredion’s key input cost, can fluctuate significantly, half of Ingredion’s core sales are priced on a cost-plus basis, which essentially locks in returns roughly in line with the company’s cost of capital. For the remaining half of core sales, the company’s active hedging strategy should help minimize ROIC volatility in the years to come. As evidence of the stability of its business, Ingredion generated positive economic profits during both the financial crisis and the North American corn drought of 2012.

  • Alliance Data Rebounds
    Posted by on June 18th, 2018 at 10:30 am

    Shares of Alliance Data Systems (ADS) got off to a terrible start this year. On January 12, ADS got as high as $278.33. By May 3, it was down to $193.87.

    Since then, it’s recovered a lot of lost ground. This morning, ADS got up to $236.96. That’s a gain of 22% in a few weeks. The stock is still down for the year, but the rebound has been impressive. ADS is now above its 50- and 200-day moving averages.

  • Morning News: June 18, 2018
    Posted by on June 18th, 2018 at 7:14 am

    Brent Bounces on Muted Production- Increase Reports

    Xi to Counter Trump Blow for Blow in Unwanted Trade War

    U.S.-China Trade Standoff Weighs on Global Shares

    Bitcoin Could Break the Internet, Central Bank Overseer Says

    Is the Gig Economy a Myth?

    Almost 1 Million People ‘Testing’ WhatsApp Payments Service In India

    Google to Invest $550 Million in China E-Commerce Site JD

    How AT&T Beat the Government

    Time Warner Is Just What AT&T Needed to Take on Facebook and Google

    Amazon Tightens Grip on a New Medium: Live Streams of Video Games

    Unilever Demands Influencer Marketing Business Clean Up Its Act

    Audi Chief Rupert Stadler Arrested in Diesel Emissions Probe

    Roger Nusbaum: Financial Independence = FU Money

    Ben Carlson: Why The Next Bear Market May Feel More Painful

    Jeff Miller: What is Working, and Will It Persist?

    Be sure to follow me on Twitter.

  • CWS Market Review – June 15, 2018
    Posted by on June 15th, 2018 at 7:08 am

    “There are no patents in finance. Everything has a decay curve, in terms of its margins.” – Stephen Schwarzman

    Well, it happened. The Federal Reserve decided to raise interest rates this week, and the stock market didn’t seem to mind much at all. In fact, on Thursday, the Nasdaq closed at an all-time high (see below), and the broader S&P 500 is close to a three-month high.

    The big headline from the Fed meeting is that Mr. Powell & Co. now plan on raising rates two more times this year. Their earlier projection had been for one more increase. This is a good example of the headlines being narrowly true yet missing the larger picture. The fact is that the Fed’s long-term path for interest rates hasn’t changed one iota. I’ll explain what it all means in a bit.

    The big news for our Buy List was that on Monday, it was reported that Stryker was going to buy Boston Scientific. Then, 48 hours later, Stryker wasn’t going to buy Boston Scientific. So, was this Wall Street’s version of Runaway Bride? Or maybe Runaway Groom? I’ll bring you all the details. But first, let’s look at what the Fed has in store for us.

    The Federal Reserve Hiked Rates

    The Federal Reserve met again this week, and for the seventh time this cycle, the central bank decided to raise overnight interest rates. The new target range for Fed funds is 1.75% to 2.00%. This move was widely expected. The Fed had been quietly signaling to financial markets that a rate hike was coming. The futures market in Fed funds was nearly unanimous that rates were about to rise.

    Even though this week’s move was expected, there were a few interesting items I wanted to highlight for you. First off, Chairman Jay Powell said that he’ll hold press conferences at all FOMC meetings starting next year. That’s good to hear. The current schedule has him holding press conferences at every other meeting. This is another sign of more transparency from the Fed.

    I also like how Powell speaks in plain English. I like to tease Fed officials for lapsing into “Fedspeak,” which is my pet name for their official-sounding econo-babble. Alan Greenspan once said, “I guess I should warn you, if I turn out to be particularly clear, you’ve probably misunderstood what I’ve said.” Not with Powell. I think it’s noteworthy that he’s a lawyer by background and not an economist. Powell speaks clearly and to the point. We need more of this.

    For example, the Fed cut way back on the length of its policy statement. I’ve been calling for this for years. There’s no need for a policy statement to run on for several hundred words. Just tell what you did, why you did it and move on.

    This week’s policy statement said that the jobs market is strong, consumer spending looks good and inflation is holding near 2%. The previous statement said that economic activity is rising at a “moderate” rate. Now it’s rising at a “solid” rate. (Yes, there are people whose job it is to freak out about these minor changes.) Let me boil it down for you—the key takeaway is that things are slowly getting better, and the Fed is going to continue raising rates.

    That’s fine for us. The Fed is still some distance away from harming the market or the economy, but the danger zone is no longer purely theoretical. The recession was a long time ago. While the recovery has been uneasy, it’s been stable. With this meeting, the Fed updated its economic forecasts. This is what I was most interested in. Here’s a look at the dividend yield of the S&P 500 (red) along with the two-year Treasury yield (blue). The two-year is often pretty close to the Fed funds rate. Notice how the blue line went from nearly 0% and it just jumped above the red.

    The media reported that the Fed’s forecast was more “hawkish,” meaning more willing to raise interest rates to fight off inflation. This is true, but I think a lot of investors were led astray by the headline. It’s true that the median forecast on the Fed now sees the need for two more rate hikes this year. However, when we look at the individual forecasts, only one vote changed. So while there is indeed a majority on the Fed that sees the need for two more hikes this year, it’s a majority by a single vote. Let’s remember that the Fed’s forecasts are typically overly hawkish early on, and they tend to correct to the dovish side as time goes by. That could easily happen again.

    The median Fed member now sees two more increases this year, plus three more next year (again, by one vote). That would bring the range on Fed funds to 3.00% to 3.25%. This would be followed by one more rate increase in 2020.

    Let me make clear that the idea of forecasting rate hikes so far in advance is utter folly. But the important point for us is that the 2020 forecast is the exact same forecast we saw at the previous Fed meeting. In other words, the Fed hasn’t changed its target for rate hikes; it merely altered the path slightly. Yet some traders mistook this for a bigger deal that it really is.

    Here’s where we stand. Let’s say the Fed hikes again in September. That will bring real rates all the way up to 0%. The real short-term interest rate is one of the strongest variables in determining the direction of stock prices. The earliest we would have to worry about the Fed causing havoc is probably still a year away.

    The housing market still looks good. The labor market is strong. The Atlanta Fed pegs Q2 GDP growth at 4.8%. That’s huge, but it’s just an estimate. The 2/10 Spread, a key finance metric, got down to 35 basis points on Thursday. That’s the narrowest in nearly eleven years, but it’s still positive. Tuesday’s inflation report showed that core prices rose 2.24% in the last year. That’s pretty good.

    Overall, this is close to the sweet spot for the economy and the market. The biggest challenge for us is that the market has been rewarding lower-quality stocks. That’s why the Nasdaq has been so strong lately. The Nasdaq Composite is already up more than 12.4% this year.

    Around here we favor high-quality stocks, and those haven’t been reaping the market’s big gains. Do not be tempted by the easy profits in lower-quality shares! Low quality typically has its day in the sun, but it ends badly. Our strategy, meanwhile, continues to do well. Continue to focus on a core group of high-quality stocks such as those you see on our Buy List. Now let’s turn this week’s almost big story.

    Kalamazoo Scientific?

    On Monday, the Wall Street Journal reported that Stryker (SYK) made an offer to buy Boston Scientific (BSX). Trading in shares of both stocks was halted before Boston Scientific confirmed the story. The WSJ didn’t disclose any details, but it would have been a major deal. I like both stocks a lot, especially Stryker. The Kalamazoo-based company has been a Buy List member since 2008.

    A deal between the two makes some sense. Stryker is a leader in orthopedics, neuro and spine, while BSX is big in cardio. There’s also been a wave of mergers rolling over the industry. In fact, we were the beneficiaries of this wave last year when Becton, Dickinson snapped up CR Bard. We also rode the run-up in Express Scripts when they put themselves on the market.

    Since Stryker was the would-be acquirer, its stock fell 5.1% on Monday, while BSX jumped 7.4%. Stryker fell another 4.3% on Tuesday (see below). Still, this deal seemed pretty shaky. I get the feeling they were pursuing a deal because they thought they had to, not because they wanted to.

    Then on Wednesday, the whole thing fell apart. Stryker took the unusual step of releasing a regulatory filing. While acknowledging that they don’t typically comment on such matters, Stryker said, “Stryker is not in discussions with Boston Scientific Corporation regarding a potential acquisition.” Of course, that doesn’t mean they had not been in discussions.

    I’m assuming BSX shot them down. I can’t say I’m disappointed. Big deals are hard to pull off, and bigger isn’t necessarily better in the business world. There are lots of examples of mega-mergers turning out to be duds. I’d rather see Stryker pursue a deal that they want to get instead of one that feels forced.

    Stryker is a very good outfit. A few weeks ago, they beat earnings by eight cents per share. The CEO said, “We had an excellent start to 2018 with strong organic sales growth, operating margin and adjusted EPS in the first quarter.” The company also raised its full-year forecast. Their initial range was $7.07 to $7.17 per share. Now they see 2018 coming in between $7.18 and $7.25 per share.

    Shares of Stryker rebounded a little after the deal fell through. If you have been looking to add Stryker to your portfolio, this is a good opportunity. For Q2, Stryker expects $1.70 to $1.75 per share. That’s pretty good. Look for another impressive report in late July.

    Before I go, I want to raise a few of our Buy Below prices. I’m lifting Fiserv (FISV) to $81 per share. The stock hit a new 52-week high on Thursday. I’m raising Moody’s (MCO) to $190 per share. The credit-rating agency is a 19% winner for us this year. I’m also going to raise Intercontinental Exchange (ICE) to $79 per share. Lastly, I’m raising FactSet (FDS) to $223 per share. FDS will report earnings again on June 26.

    That’s all for now. There’s not much on tap for next week in terms of market news, although we will get some key reports on housing. On Tuesday, the housing-starts report comes out. Then on Wednesday, we’ll see existing home sales. I’ll be curious to see if higher rates have had an impact on the housing market. So far, the evidence is pretty thin. Be sure to keep checking the blog for daily updates. I’ll have more market analysis for you in the next issue of CWS Market Review!

    – Eddy

    Syndication Partners

    I’ve teamed up with Investors Alley to feature some of their content. I think they have really good stuff. Check it out!

    3 Stocks Raising Dividends in July

    There is a general misconception that rising interest rates are always bad for real estate investment trust (REIT) values. However, history shows that REITs have outperformed 75% of the time during the last 16 periods of rising interest rates. One reason is that quality REITs will grow their dividends, and if the dividend increases keep up or exceed the interest rate increases, you are better off owning the REIT shares.

    Buying shares in the month before a dividend announcement is one strategy that can produce a quick start to a new for you REIT investment. Most REITs increase their dividend rate once a year, and then pay that new rate for the next four quarters. From the way share prices change, it is apparent the investing world is not aware of the timing of dividend boosts in the REIT world. I maintain a database of about 130 REITs and include which month each usually announces its dividend hikes.

    Summer is one season with the fewest number of increase announcements. However, it can also be an opportunity because the market is not looking for higher dividend rate announcements. There are three REITs that should announce higher payouts in July. You can pick up shares now, and when a new higher dividend is announced you get the double bonus of a possible share price increase on the news and the guaranteed benefit of a higher yield than the current quoted rate. Here are three stocks to consider buying in June for a July dividend increase.

    5 Low Risk Income Stocks Profiting from Stock Market Volatility

    After a long period of low volatility, the measurement of stock price movement has moved much higher in 2018. Higher volatility is usually accompanied by big down days in the stock market. Over the last five months, the U.S. market has turned from a place of easy profits to one that has been tough on investor portfolio values. To make lemonade from lemons, consider those investments products that can pay you more based on increased volatility.

    Measured volatility increases when the stock market goes down. The reason the metric was so low in 2017 is because down days were few and of limited magnitude. A recent article from Bloomberg highlighted the fact that in 2018 the average down day move of the S&P 500 this year has been 24% greater than the average up day gain. This is the largest gap since 1948. As I noted, down days result in increased volatility, so it’s understandable that even though the current S&P 500 is close to where it started the year, volatility has made stock investing more nerve racking.

    The widely quoted volatility index or VIX is derived from the prices of options contracts trading against the S&P 500. Many investors do not know that VIX is just a measure of options prices. This means that when volatility or VIX is elevated, traders who sell options are making more money. While options trading can be complicated and risky, there are income focused investment products that use option selling to enhance cash flow and support dividend payments from a portfolio that without options would not carry as attractive a yield.

    You can find these buy-write or covered call products in the form or ETFs or closed-end funds. When you invest in one of these funds, you should look for recent dividend increases due to higher volatility, or if you buy shares in funds that haven’t yet increased payouts, sell the shares if you don’t get a dividend boost in the next quarter or two.

    Here are five funds to consider.

  • Morning News: June 15, 2018
    Posted by on June 15th, 2018 at 7:02 am

    As China Curbs Borrowing, Growth Shows Signs of Faltering

    Draghi Ends ECB Bond-Buying Era Saying Economy Can Beat Risk

    Oil Set for Weekly Loss in London as OPEC Clash on Supply Looms

    China’s Didi Chuxing Continues Its International Expansion With Australia Launch

    Top Facebook Strategist to Step Down

    The AT&T-Time Warner Merger Hurts Consumers

    Disney-Fox? Apple-CBS? Facebook-Bravo?

    The Hidden Cost of Trying to Land Amazon’s HQ2

    Ethereum Spikes After the SEC Declares It’s Not a Security

    Rolls-Royce Jet Engine Flaws Spell Opportunity for GE

    ZTE’s Shares Slide on Trade War Jitters, Lost 30% of Market Value This Week

    Unicorns Are Worth Twice As Much As Last Month

    Blue Harbinger: Have You Ever Tried To Design A Trading System?

    Joshua Brown: Gundlach’s Bond Call

    Ben Carlson: When the Unexpected Leads to the Unexpected

    Be sure to follow me on Twitter.